The wrong way to stop fake drugs

Getty Images

Robert Granville reaches for a medicine bottle as he takes his prescription pills on February 25, 2009 in Miami, Florida.

  • Title:

    Phake
  • Format:

    HardCover
  • Hardcover ISBN:

    978-0-8447-7232-5
  • Buy the Book

Article Highlights

  • 3% of the 9,600 online pharmacies meet industry standards; and yet, the answer is not to outlaw this business entirely

    Tweet This

  • Buying drugs online should remain a limited option for desperate cash buyers — sick people with limited resources, insurance coverage

    Tweet This

  • Developing a treaty is the only way to begin to stamp out the international fake drug trade

    Tweet This

IN 2007-8, when counterfeit versions of heparin, a blood-thinning drug, were shipped from China to the United States market, 149 people died. In the last few months, bogus versions of the cancer drug Avastin, apparently shipped from the Middle East, have surfaced in clinics in California, Illinois and Texas. Thankfully, so far as we know, they haven’t killed anyone, but more and more cases of dangerous fake drugs are being reported by the Food and Drug Administration. Numerous incidents surely go unreported, the evidence swallowed, the deaths incorrectly attributed to natural causes.

Fighting the fake drug menace is like playing whack-a-mole. It is technically illegal for individuals to order drugs online from other countries. And yet no sooner does the F.D.A. shut down one dubious online pharmacy than another pops up. According to the National Association of Boards of Pharmacy, only 3 percent of the 9,600 online pharmacies it has reviewed complied with industry standards. Many were based overseas, so their sales to Americans were illegal; others did not require doctors’ prescriptions. And some were very likely peddling dangerous counterfeit drugs.

And yet, the answer is not to outlaw this business entirely. Foreign versions of drugs can cost roughly half what they do in the United States. For the millions of Americans who are uninsured or underinsured, buying from international, credentialed online pharmacies could provide access to the medicines they need at a price they can afford. The online market for drugs is already substantial, with probably more than a million Americans regularly participating. But it is growing slowly because of concern about drug safety and, of course, legality. While the F.D.A. does not prosecute individual consumers whose purchases present no threat to themselves or the public and grants some waivers to those buying less than three months’ supply of a drug from abroad, most are still technically considered criminals.

"Careless buyers play Russian roulette, but those who look for credentialed sites can purchase safe drugs at a significant discount." - Roger BateThe logic behind the current law is that it protects Americans from buying dangerous drugs. But there are better ways to guarantee that. In a recent National Bureau of Economic Research paper, I assessed the quality and price of drugs procured through Internet pharmacies. As expected, I found several foreign sites that sold fake drugs. But of the international Web pharmacies certified by the Canadian International Pharmacy Association or PharmacyChecker.com — 23 in all, with 211 drugs sampled — all passed quality-control tests. After all, they were the same drugs made by the same companies, just in different locations.

Careless buyers play Russian roulette, but those who look for credentialed sites can purchase safe drugs at a significant discount. Some Americans know this, but far more should. And it should be made entirely legal for them to do so.

Buying drugs online from overseas isn’t for everyone. It should remain a limited option for desperate cash buyers — sick people with limited resources and insurance coverage — not a way for well-insured patients to reduce their co-pay. American health insurance companies should not be required to reimburse consumers for these drugs, because that would effectively import foreign governments’ price controls into the United States and undermine American companies’ research and development budgets.

"A global treaty against fake drugs (and the financing to enforce it) could work to eliminate these safe havens and ensure that the perpetrators of fraud have nowhere to hide." - Roger BateNonetheless, American pharmacists will most likely lose some business, and they will lobby hard against such a change. And no doubt some bad drugs will slip through, which will probably stop the FDA from backing the idea. But as the problems with heparin and Avastin show, fake drugs leak into the United States already. The Internet is not the problem; the problem is that United States law cannot reach many of the criminals who perpetrate the frauds because most never set foot in America.

We can do something about that. These criminal networks flourish across Southeast Asia, Latin America and the Middle East. Turkey and the Caribbean act as major transit points, and countries like Panama launder the billions in profit. A global treaty against fake drugs (and the financing to enforce it) could work to eliminate these safe havens and ensure that the perpetrators of fraud have nowhere to hide. We have treaties against fake currency and the narcotics trade, but as the medical journal The Lancet recently noted, we do not have one for fake drugs. Developing such a treaty — the World Health Organization is the obvious place to start — will take time, but it is the only way to begin to stamp out the international fake drug trade.

In the meantime, poor Americans should know how to buy their medicines online safely and should be allowed to do so. In an attempt to protect poor, uninsured and underinsured Americans from unsafe drugs, we are making sure that some go without drugs completely. It is time the law was changed.

Roger Bate, a resident scholar at AEI, is the author of the forthcoming book “Phake: The Deadly World of Falsified and Substandard Medicines.”

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate
  • Roger Bate is an economist who researches international health policy, with a particular focus on tropical disease and substandard and counterfeit medicines. He also writes on general development policy in Asia and Africa. He writes regularly for AEI's Health Policy Outlook.
  • Phone: 202-828-6029
    Email: rbate@aei.org
  • Assistant Info

    Name: Katherine Earle
    Phone: (202) 862-5872
    Email: katherine.earle@aei.org

What's new on AEI

image How to beat Memorial Day traffic forever
image Bernanke stumbles, markets react
image Don't edit the First Amendment
image Home Economics
AEI on Facebook
Events Calendar
  • 20
    MON
  • 21
    TUE
  • 22
    WED
  • 23
    THU
  • 24
    FRI
Tuesday, May 21, 2013 | 5:00 p.m. – 6:30 p.m.
Free beer: Liberating libations from ‘Bootleggers and Baptists’

Join us for a discussion of the history and future of federal and state alcohol regulation and competition, followed by a reception with beer, wine, and spirits.

Wednesday, May 22, 2013 | 5:00 p.m. – 6:30 p.m.
NCLB sanctions: Tests taken, lessons learned

Join education scholars and practitioners for a discussion about the latest NCLB research and its implications for future education policy.

Thursday, May 23, 2013 | 12:00 p.m. – 1:30 p.m.
Competing visions of the common good: Rethinking help for the poor

What shared commitments do we have as citizens and neighbors to care for one another? How can a proper ordering of America’s political economy enable the most people to have the best life? At this event, Rep. Frank Wolf (R-VA), a longtime champion of human rights causes, and AEI President Arthur Brooks will join Wallis in addressing these and other questions.

Event Registration is Closed
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.